Farhad Hafezi
Farhad Hafezi is a prominent Swiss eye surgeon and researcher. Hafezi first gained recognition as a leading retina researcher in 1994, having been the first to discover a gene responsible for light-induced retinal degeneration. However, he changed his research focus to the cornea in 2003, and it is this work, particularly on corneal collagen cross-linking (CXL), which he helped pioneer, and advanced laser refractive surgery that he is internationally known for today. Hafezi's current clinical and laboratory research is focused on gaining a better understanding of the cornea. His research group at the University of Zurich has three main research foci: * Examining the structure and function of the cornea at the molecular level, * Investigating corneal cell biology, and * Translational research initiatives dedicated to improving laser refractive surgery techniques that can help address certain complications that can arise following these procedures.Hafezi is considered to be a leading expert and key opinion leader in the development and translation of CXL and its multiple applications in the field of ophthalmology, including the treatment of corneal ectatic disorders like keratoconus, pellucid marginal degeneration and post-LASIK ectasia. Hafezi and his colleagues have also pioneered the use of CXL for the treatment of corneal infections, calling the technique “photoactivated chromophore for infectious keratitis cross-linking”, or PACK-CXL. Hafezi has published almost 200 articles in various peer-reviewed scientific journals since 1993, including Nature Medicine, Nature Genetics, Investigative Ophthalmology & Visual Science (IOVS), the Journal of Refractive Surgery, and Cell Death & Differentiation.
His work in the field of corneal collagen cross-linking has led him to receive a number of international awards. In 2014, 2016, 2018, 2020 and 2023 his peers ranked Hafezi as one of the top 100 most influential people in ophthalmology.
He is currently a professor of ophthalmology at the University of Geneva, an adjunct clinical professor of ophthalmology at the Keck School of Medicine, University of Southern California, a research group leader of the Ocular Cell Biology Group at the Center for Applied Biotechnology and Molecular Medicine at the University of Zurich, a visiting professor at the University of Wenzhou, China, a research professor of ophthalmology at the NYU Grossman School of Medicine, and medical director of the ELZA Institute. Provided by Wikipedia
-
1
-
2
-
3by Duoduo Wu, Dawn Ka-Ann Lim, Dawn Ka-Ann Lim, Blanche Xiao Hong Lim, Blanche Xiao Hong Lim, Nathan Wong, Farhad Hafezi, Farhad Hafezi, Farhad Hafezi, Farhad Hafezi, Farhad Hafezi, Ray Manotosh, Ray Manotosh, Chris Hong Long Lim, Chris Hong Long Lim, Chris Hong Long Lim, Chris Hong Long LimGet full text
Published 2021-07-01
Article -
4
-
5
-
6
-
7
-
8
-
9
-
10by Rashmi Deshmukh, Farhad Hafezi, George D Kymionis, Sabine Kling, Rupal Shah, Prema Padmanabhan, Mahipal S SachdevGet full text
Published 2019-01-01
Article -
11
-
12
-
13by Mirko R. Jankov II, Farhad Hafezi, Maja Beko, Zora Ignjatovic, Branislav Djurovic, Vujica Markovic, Paulo SchorGet full text
Published 2008-12-01
Article -
14
-
15
-
16by Cosimo Mazzotta, Frederik Raiskup, Farhad Hafezi, Emilio A Torres-Netto, Ashraf Armia Balamoun, Giuseppe Giannaccare, Simone Alex BagagliaGet full text
Published 2021-05-01
Article -
17
-
18by Sally Hayes, Craig Boote, Christina S Kamma-Lorger, Madhavan S Rajan, Jonathan Harris, Erin Dooley, Nicholas Hawksworth, Jennifer Hiller, Nick J Terill, Farhad Hafezi, Arun K Brahma, Andrew J Quantock, Keith M MeekGet full text
Published 2011-01-01
Article